医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Cook Medical’s Leadership Updates in Asia-pacific Reinforce Focus on Growth and Physician Relationships

2019年11月13日 AM09:00
このエントリーをはてなブックマークに追加


 

HONG KONG

Cook Medical announced today that Jean-Marc Creissel has been named vice president and director of Asia-Pacific.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191112006126/en/

Jean-Marc Creissel, vice president and director of Cook Medical Asia-Pacific. (Photo: Business Wire)

Jean-Marc Creissel, vice president and director of Cook Medical Asia-Pacific. (Photo: Business Wire)

In his new role, Creissel will lead the Asia-Pacific teams to transform Cook Medical into a truly modern global company with patients, customers and employees at the heart of daily operations. He will grow the teams’ capabilities to help deliver innovative medical solutions and enhance patient care worldwide.

“Jean-Marc has a deep understanding of the Asia-Pacific region because he has served Cook Medical in various positions for nearly 30 years,” said Pete Yonkman, president of Cook Group and Cook Medical. “We are confident that he will continue to expand opportunities for physicians in this region to access Cook’s highly advanced and minimally invasive devices.”

Creissel joined Cook in 1990 and has led several global and regional teams in the USA, Europe and Asia-Pacific regions. His work includes being the global business leader of Cook Medical’s Urology specialty and, most recently, vice president of operations in Greater China and Southeast Asia. Creissel will remain based in Hong Kong.

Creissel succeeds Barry Thomas, who is stepping toward retirement after more than 10 years of leadership in the region. Thomas will focus on his role as vice president and representative director of Cook Japan, where he will advise operations and strategic planning. He will align the needs of the local team with the regional and global functions that support physician connections in Japan. Thomas will remain based in Australia and will have dedicated time spent in the Cook Japan office.

Thomas has 19 years of experience in various leadership roles at Cook Medical. He was appointed vice president and director of Asia-Pacific in 2008, driving the company to grow and expand its business in the region. Additionally, he has over 35 years of expertise and international leadership in the medical device and pharmaceutical industries.

“On behalf of Cook Group, I thank Barry for his tremendous dedication to serving patients in the region,” continued Yonkman. “Under his leadership, our team in Asia Pacific has grown from 60 people to more than 600 in the last 10 years. We are grateful that Barry will lead and coach our teams in Japan, one of our significant areas for growth in Asia.”

About Cook Medical

Since 1963, Cook Medical has worked closely with physicians to develop technologies that eliminate the need for open surgery. Today we are combining medical devices, biologic materials and cellular therapies to help the world’s healthcare systems deliver better outcomes more efficiently. We have always remained family owned so that we have the freedom to focus on what we care about: patients, our employees and our communities.

Find out more at www.cookmedical.com, or on social media:
Facebook www.facebook.com/CookMedicalAUS
Twitter @CookMedicalAPAC
LinkedIn linkedin.com/company/cookmedicalapac

Further interviews and hi-res pictures are available on request.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191112006126/en/

CONTACT

Barbara Yeung

Manager, Corporate Brand and Communications, Asia Pacific, Cook Medical

Email: barbara.yeung@cookmedical.com

Phone: +852.9191.5037

同じカテゴリーの記事 

  • EverEx Secures iF Design Award for “MORA,” a Leading Musculoskeletal Rehabilitation Solution
  • Zai Lab Partner Novocure Announces METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer
  • SillaJen Submits CSR to the US FDA for REN026 Study in Patients with RCC
  • Oriola Partners With HCLTech to Enhance Customer Experience Through Digital Transformation
  • Takeda将在近期召开的股东大会上公布董事会候选人名单